Clinical Implications of Pre- and Postoperative Circulating Tumor DNA in Patients with Resected Pancreatic Ductal Adenocarcinoma

被引：0
|
作者：
Takuro Yamaguchi
Kenichiro Uemura
Yoshiaki Murakami
Naru Kondo
Naoya Nakagawa
Kenjiro Okada
Shingo Seo
Eiso Hiyama
Shinya Takahashi
Taijiro Sueda
机构：
[1] Hiroshima University,Department of Surgery, Graduate School of Biomedical and Health Sciences
[2] Hiroshima University,Natural Science Center for Basic Research and Development
[3] Hiroshima City Aki Hospital,Department of Surgery
来源：
Annals of Surgical Oncology | 2021年 / 28卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：3135 / 3144
页数：9
相关论文
共 50 条
  • [21] Novel Metabolomics Serum Biomarkers for Pancreatic Ductal Adenocarcinoma by the Comparison of Pre-, Postoperative and Normal Samples
    Zhang, Xiaohan
    Shi, Xiuyun
    Lu, Xin
    Li, Yiqun
    Zhan, Chao
    Akhtar, Muhammad Luqman
    Yang, Lijun
    Bai, Yunfan
    Zhao, Jianxiang
    Wang, Yu
    Yao, Yuanfei
    Li, Yu
    Nie, Huan
    [J]. JOURNAL OF CANCER, 2020, 11 (16): : 4641 - 4651
  • [22] Frequency and oncologic outcomes of KRAS mutations in circulating tumor DNA of patients with pancreatic ductal adenocarcinoma.
    Yousef, Mahmoud M. G.
    Hurd, Mark W.
    Yousef, Abdelrahman M. G.
    Snyder, Rebecca A.
    Knafl, Mark
    Fanaeian, Mohammad Mahdi
    Chacko, Ray
    Peterson, Jennifer
    Smaglo, Brandon George
    Wolff, Robert A.
    Pant, Shubham
    Lee, Michael Sangmin
    Overman, Michael J.
    Tzeng, Ching-Wei D.
    Katz, Matthew H. G.
    Wang, Huamin
    Maitra, Anirban
    Ludmir, Ethan B.
    Shen, John Paul Y. C.
    Zhao, Dan
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (3_SUPPL) : 636 - 636
  • [23] Prognostic Utility of Pre- and Postoperative Circulating Tumor DNA Liquid Biopsies in Patients with Peritoneal Metastases
    Baumgartner, Joel M.
    Riviere, Paul
    Lanman, Richard B.
    Kelly, Kaitlyn J.
    Veerapong, Jula
    Lowy, Andrew M.
    Kurzrock, Razelle
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2020, 27 (09) : 3259 - 3267
  • [24] Genomic profiling of circulating tumor DNA (ctDNA) from patients (pts) with pancreatic ductal adenocarcinoma (PDA).
    Bahary, Nathan
    He, Jie
    Bailey, Mark
    Zhong, Shan
    Li, Gerald
    Young, Lauren
    Singhi, Aatur D.
    Stephens, Phil
    Ali, Siraj Mahamed
    Singal, Gaurav
    Schrock, Alexa Betzig
    Chung, Jon
    Ross, Jeffrey S.
    Miller, Vincent A.
    George, Ben
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [25] Circulating Tumor Cells as a Biomarker in Pancreatic Ductal Adenocarcinoma
    Liu, Han
    Sun, Bo
    Wang, Shengnan
    Liu, Congjin
    Lu, Yun
    Li, Ding
    Liu, Xingdang
    [J]. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY, 2017, 42 (01) : 373 - 382
  • [26] DNA Damage Repair Defects and Survival Outcomes for Patients With Resected Pancreatic Ductal Adenocarcinoma
    Chang, Amy E.
    Radke, Marc R.
    Zhen, David B.
    Baker, Kelsey K.
    Coveler, Andrew L.
    Wong, Kit Man
    Pillarisetty, Venu G.
    Reddi, Deepti
    Redman, Mary W.
    Swisher, Elizabeth
    Chiorean, Elena Gabriela
    [J]. PANCREAS, 2021, 50 (05) : E50 - E52
  • [27] Clinical Relevance of Cancerization of Ducts in Resected Pancreatic Ductal Adenocarcinoma
    Kinny-Koester, Benedict
    Ahmad, Yembur
    Pflueger, Michael J.
    Habib, Joseph R.
    Fujikura, Kohei
    Hutchings, Danielle
    Cameron, John L.
    Shubert, Christopher R.
    Lafaro, Kelly J.
    Burkhart, Richard A.
    Burns, William R.
    Javed, Ammar A.
    Yu, Jun
    Hruban, Ralph H.
    Wood, Laura D.
    Thompson, Elizabeth D.
    He, Jin
    [J]. PANCREAS, 2024, 53 (06) : e528 - e536
  • [28] Circulating tumor DNA methylation as markers for early detection of pancreatic ductal adenocarcinoma (PDAC).
    Liu Xiaoding
    Guo Shiwei
    Ma Chengcheng
    Li Yatong
    Liu Xiaoqian
    Zhang Zhiwen
    Yu Lianyuan
    Dai Menghua
    Shen Shuo
    Wu, Huanwen M.
    Su Zhixi
    He Qiye
    Liu Rui
    Gang Jin
    Liang Zhiyong
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (03)
  • [29] Diagnostic and prognostic value of KRAS mutations in circulating pancreatic ductal adenocarcinoma tumor DNA
    Yang, Xiaowei
    Xu, Wei
    Tian, Xiuyun
    Wu, Jianhui
    Lv, Ang
    Li, Chengpeng
    Guan, Xiaoya
    Qian, Honggang
    Hao, Chunyi
    [J]. TRANSLATIONAL CANCER RESEARCH, 2018, 7 (03) : 622 - 633
  • [30] Characterization of RARRES1 Expression on Circulating Tumor Cells as Unfavorable Prognostic Marker in Resected Pancreatic Ductal Adenocarcinoma Patients
    Nitschke, Christine
    Markmann, Benedikt
    Tolle, Marie
    Kropidlowski, Jolanthe
    Belloum, Yassine
    Goetz, Mara R.
    Schluter, Hartmut
    Kwiatkowski, Marcel
    Sinn, Marianne
    Izbicki, Jakob
    Pantel, Klaus
    Gungor, Cenap
    Uzunoglu, Faik G.
    Wikman, Harriet
    [J]. CANCERS, 2022, 14 (18)
12345